Stay updated on Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer
Sign up to get notified when there's something new on the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page.

Latest updates to the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page
- Check4 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed in the record history, reflecting routine page maintenance with no changes to trial content or status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision: v3.3.3 now appears in the page footer, and references to HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check53 days agoChange DetectedA new revision, v3.3.2, has been added to the study's history, and the previous revision v3.2.0 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedThe funding/operating status notice banner at the top of the page has been removed. The change affects only presentation and does not alter the trial data or status.SummaryDifference0.8%

- Check75 days agoChange DetectedRecord History shows a new version entry with updated status and dates, reflecting routine updates to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check104 days agoChange DetectedUpdated operating status notice and new version (v3.2.0), replacing the previous v3.1.0. The page now provides current guidance on NIH Clinical Center operations and references official status sources.SummaryDifference13%

Stay in the know with updates to Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page.